%0 Journal Article
%T Everolimus, a further step in ¡®targeted¡¯ antineoplastic therapy?
%A Wilfried B¨¹chler
%J European Journal of Oncology Pharmacy
%D 2009
%I Pharma Publishing & Media Europe
%X Everolimus is a representative of a new class of antineoplastic agents offering new therapeutic options even for asyet refractory carcinomas. Alook at the biochemical pathways involved helps understand desired and adverse effects.
%U http://www.ppme.eu/Publications/EJOP/Journal-information/Previous-issues/EJOP-Vol.3-2009-Issue-2/New-Drug-Update/Everolimus-a-further-step-in-targeted-antineoplastic-therapy